ArticleFrontiers in medicine2025
PMPred-AE: a computational model for the detection and interpretation of pathological myopia based on artificial intelligence.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Comparative Analysis of CNN and Transformer Models for Multi-Class Diabetic Retinopathy Grading Using Fundus Images.Diagnostics (Basel, Switzerland) · 2026Article
- SpaMFG: a spatial multi-omics integration method based on feature grouping.Bioinformatics (Oxford, England) · 2026Article
- MVFAN-Kcr: A Multi-View Feature Fusion and Attention-Based Network for Lysine Crotonylation Site Identification.Interdisciplinary sciences, computational life sciences · 2026Article
- CataCon: a contrastive graph representation learning framework for catalyst prediction.Journal of cheminformatics · 2026Article
- Rethinking bioinformatics in liquid-liquid phase separation: data resources, predictive models, and an event-centric perspective.Briefings in bioinformatics · 2026Review
- PepLM-GNN: A graph neural network framework leveraging pre-trained language models for peptide-protein binding prediction.PLoS computational biology · 2026Article
- FKSUDDAPre: A drug-disease association prediction framework based on F-TEST feature selection and AMDKSU resampling with interpretability analysis.PLoS computational biology · 2026Article
- Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics.Briefings in bioinformatics · 2026Article
- BiGvCL: bipartite graph-based cross-domain contrastive learning model for the predicting drug-gene interactions.Briefings in bioinformatics · 2026Article
- PepGraphormer: an ESM-GAT hybrid deep learning framework for antimicrobial peptide prediction.Journal of cheminformatics · 2026Article
- CMsiRNAdb: a database of chemically modified SiRNA silencing efficiency for nucleic acid drug design.BMC bioinformatics · 2026Article
- RWRGDR: Random Walk and GraphSAGE-based Framework for Enhanced Drug Repositioning.Current drug targets · 2026Article
- An Explainable Deep Learning Model for Clathrin Protein Prediction Using a DCT-Enhanced Position-Specific Scoring Matrix.Current drug targets · 2026Article
- Interferon-primed immune landscapes predict immune-related adverse events during immune checkpoint inhibitor therapy.Frontiers in cell and developmental biology · 2026Article
- SpaMWGDA: Identifying spatial domains of spatial transcriptomes using multi-view weighted fusion graph convolutional network and data augmentation.PLoS computational biology · 2025Article
- Brain Stroke Classification Using CT Scans with Transformer-Based Models and Explainable AI.Diagnostics (Basel, Switzerland) · 2025Article
- A deep learning model for epidermal growth factor receptor prediction using ensemble residual convolutional neural network.Scientific reports · 2025Article
- NeXtMD: a new generation of machine learning and deep learning stacked hybrid framework for accurate identification of anti-inflammatory peptides.BMC biology · 2025Article
- From Detection to Prediction: Advances in m6A Methylation Analysis Through Machine Learning and Deep Learning with Implications in Cancer.International journal of molecular sciences · 2025Review
- Recent advances in deep learning for protein-protein interaction: a review.BioData mining · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pathological myopia (PM) is a serious visual impairment that may lead to irreversible visual damage or even blindness. Timely diagnosis and effective management of PM are of great significance. Given the increasing number of myopia cases worldwide, there is an urgent need to develop an automated, accurate, and highly interpretable PM diagnostic technology. Methods: We proposed a computational model called PMPred-AE based on EfficientNetV2-L with attention mechanism optimization. In addition, Gradient-weighted class activation mapping (Grad-CAM) technology was used to provide an intuitive and visual interpretation for the model's decision-making process. Results: The experimental results demonstrated that PMPred-AE achieved excellent performance in automatically detecting PM, with accuracies of 98.50, 98.25, and 97.25% in the training, validation, and test datasets, respectively. In addition, PMPred-AE can focus on specific areas of PM image when making detection decisions. Discussion: The developed PMPred-AE model is capable of reliably providing accurate PM detection. In addition, the Grad-CAM technology was also used to provide an intuitive and visual interpretation for the decision-making process of the model. This approach provides healthcare professionals with an effective tool for interpretable AI decision-making process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.